CSIMarket


Abbvie inc   (ABBV)
Other Ticker:  
 

Abbvie inc

ABBV's Fundamental analysis








Abbvie Inc 's sales fell by -5.42 % in IV. Quarter 2023 from the same quarter a year ago. Ranking at No. 599

Major Pharmaceutical Preparations industry recorded deterioration of revenues by

Abbvie Inc 's net profit deacreased by -66.67 % in IV. Quarter 2023 year on year, to $824 millions.

More on ABBV's Growth


Abbvie Inc
current PE on trailing twelve month basis is below Major Pharmaceutical Preparations industry average.

Company is currently trading with Price to Cash flow multiple of 88.32 in trailing twelve-month period.
Company
65.27
PE TTM   
Industry
2027.12
PE TTM    
Company's Price to Sales ratio is at 5.87.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.81.


More on ABBV's Valuation
 
 Total Debt (Millions $) 59,385
 Dividend TTM ($) 5.93 $
 Dividend Yield TTM (%) 3.29 %
 Revenue/Employee (TTM) $ 1,086,360
 Net Income/Employee (TTM) $ 97,460
 Receivable Turnover (TTM) 4.77
 Tangible Book Value (Per Share $) -43.35

Abbvie Inc
current PE on trailing twelve month basis is below Major Pharmaceutical Preparations industry average.

Company is currently trading with Price to Cash flow multiple of 88.32 in trailing twelve-month period.
Company
65.27
PE TTM   
Industry
2027.12
PE TTM    
Company's Price to Sales ratio is at 5.87.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.81.

Abbvie Inc Price to Book Ratio is at 30.69 lower than Indusry Avg. of 1298.49. and higher than S&P 500 Avg. of -1999.75

More on ABBV's Valuation

  Market Capitalization (Millions $) 319,117
  Shares Outstanding (Millions) 1,788
  Employees 50,000
  Revenues (TTM) (Millions $) 54,318
  Net Income (TTM) (Millions $) 4,873
  Cash Flow (TTM) (Millions $) 3,613
  Capital Exp. (TTM) (Millions $) -777
  Total Debt (Millions $) 59,385
  Dividend TTM ($) 5.93 $
  Dividend Yield TTM (%) 3.29 %
  Revenue/Employee (TTM) $ 1,086,360
  Net Income/Employee(TTM) $ 97,460
  Receivable Turnover Ratio (TTM) 4.77
  Tangible Book Value (Per Share $) -43.35

  Market Capitalization (Millions $) 319,117
  Shares Outstanding (Millions) 1,788
  Employees 50,000
  Revenues (TTM) (Millions $) 54,318
  Net Income (TTM) (Millions $) 4,873
  Cash Flow (TTM) (Millions $) 3,613
  Capital Exp. (TTM) (Millions $) -777


    ABBV's Profitability Comparisons
Abbvie Inc achieved increase in profitability, due to increase in demand and cost control. Operating Margin grew in IV. Quarter 2023 to 22.34 % from 16.38 % in III. Quarter.

Abbvie Inc net profit margin of 5.76 % is currently ranking no. 33 in Major Pharmaceutical Preparations industry, ranking no. 110 in Healthcare sector and number 1262 in S&P 500.


Profitability by Segment



  Ratio
   Capital Ratio (MRQ) 0.87
  Total Debt to Equity (MRQ) 5.71
  Tangible Leverage Ratio (MRQ) -
  Asset Turnover Ratio (TTM) 0.4
  Inventory Turnover Ratio (TTM) 5.11



Abbvie Inc achieved increase in profitability, due to increase in demand and cost control. Operating Margin grew in IV. Quarter 2023 to 22.34 % from 16.38 % in III. Quarter.

Abbvie Inc net profit margin of 5.76 % is currently ranking no. 33 in Major Pharmaceutical Preparations industry, ranking no. 110 in Healthcare sector and number 1262 in S&P 500.

More on ABBV's Key Ratios





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com